Sicras-Mainar et al [WHO] World Health Organization Collaborating Centre for Drug Statistics and Methodology. 1995. Guidelines for ATC classiﬁcation and DDD assignment. Oslo, Norway: WHO. Woodward ND, Purdon SE, Meltzer HY, et al. 2007. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical anti- psychotics: dose effects and comparison to practice effects. Schizophr Res, 89:211–24. Wu RR, Zhao JP, Liu ZN, et al. 2006. Effects of typical and atypical anti- psychotics on glucose-insulin homeostasis and lipid metabolism in ﬁrst-episode schizophrenia. Psychopharmacology (Berl), 186:572–8. 226 Neuropsychiatric Disease and Treatment 2008:4(1)